Visit COVID-19 resources

[Skip to Content]

Comment on: Estimate of incidence of ROP requiring treatment in extreme preterms and impact on service—7 year review in tertiary unit – (Eye Journal)

Oct 04
2019

Eye, Published online: 04 October 2019; doi:10.1038/s41433-019-0618-5 Comment on: Estimate of incidence of ROP requiring treatment in extreme preterms and impact on service—7 year review in tertiary unit

  • 4 October 2019

Prestigious £100,000 IGA and RCOphth research grant launched

Oct 04
2019

There are 700,000 people in the UK living with glaucoma, an eye disease that without treatment typically causes loss of vision.  Over the next ten years, glaucoma cases are predicted to rise by 22% and over 20 years by 44%.  Research is vital to improve understanding of glaucoma and develop innovative and sight-saving treatments. The

  • 4 October 2019

ROP in Asia – (Eye Journal)

Oct 03
2019

Eye, Published online: 03 October 2019; doi:10.1038/s41433-019-0620-y ROP in Asia

  • 3 October 2019

A new era for giant cell arteritis – (Eye Journal)

Oct 03
2019

Eye, Published online: 03 October 2019; doi:10.1038/s41433-019-0608-7 A new era for giant cell arteritis

  • 3 October 2019

National Recruitment Changes

Oct 03
2019

ST3 recruitment was paused for 2019 to carry out a full consultation of the College membership.  The results of this consultation are that: Entry into training will be possible above the ST1 level. Recruitment (all levels) will be done at the same time in the same location. ST4 will be the highest appointable level to

  • 3 October 2019